The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Role of Receptor Tyrosine Kinase Transmembrane Domains in Cell Signaling and Human Pathologies
Open accessAbstract
Receptor tyrosine kinases (RTKs) conduct biochemical signals via lateral dimerization in the plasma membrane, and their transmembrane (TM) domains play an important role in the dimerization process. Here we present two models of RTK-mediated signaling, and we discuss the role of the TM domains within the framework of these two models. We summarize findings of single-amino acid mutations in RTK TM domains that induce unregulated signaling and, as a consequence, pathological phenotypes. We review the current knowledge of pathology induction mechanisms due to these mutations, focusing on the structural and thermodynamic basis of pathogenic dimer stabilization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Cell Signaling by Receptor Tyrosine Kinases
Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
Olayioye, M. A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3159 · Cited by 2,434
Cation-π interactions in structural biology
Gallivan, J. P., & Dougherty, D. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9459 · Cited by 1,997
Cellular signaling by fibroblast growth factor receptors
Eswarakumar, V. P., Lax, I., & Schlessinger, J. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.001 · Cited by 1,929
Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab
Cho, H.-S., Mason, K., Ramyar, K. X., Stanley, A. M., Gabelli, S. B., Denney, D. W., & Leahy, D. J. (2003) · Nature · doi:10.1038/nature01392 · Cited by 1,612
Shiang, R., Thompson, L. M., Zhu, Y.-Z., Church, D. M., Fielder, T. J., Bocian, M., Winokur, S. T., & Wasmuth, J. J. (1994) · Cell · doi:10.1016/0092-8674(94)90302-6 · Cited by 1,329
Receptor Protein-Tyrosine Kinases and Their Signal Transduction Pathways
van der Geer, P., Hunter, T., & Lindberg, R. A. (1994) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.10.110194.001343 · Cited by 1,326
Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains
Ogiso, H., Ishitani, R., Nureki, O., Fukai, S., Yamanaka, M., Kim, J.-H., Saito, K., Sakamoto, A., Inoue, M., Shirouzu, M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00963-7 · Cited by 1,227
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen
Schechter, A. L., Stern, D. F., Vaidyanathan, L., Decker, S. J., Drebin, J. A., Greene, M. I., & Weinberg, R. A. (1984) · Nature · doi:10.1038/312513a0 · Cited by 1,175
SIGNALLING BY RECEPTOR TYROSINE KINASES
Fantl, W. J., Johnson, D. E., & Williams, L. T. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002321 · Cited by 1,086
Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth
Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A., & Leder, P. (1996) · Cell · doi:10.1016/s0092-8674(00)81069-7 · Cited by 1,070
Bargmann, C. I., Hung, M.-C., & Weinberg, R. A. (1986) · Cell · doi:10.1016/0092-8674(86)90779-8 · Cited by 1,006
A Transmembrane Helix Dimer: Structure and Implications
MacKenzie, K. R., Prestegard, J. H., & Engelman, D. M. (1997) · Science · doi:10.1126/science.276.5309.131 · Cited by 954
Takahashi, H., & Shibuya, M. (2005) · Clinical Science · doi:10.1042/cs20040370 · Cited by 953
An Open-and-Shut Case? Recent Insights into the Activation of EGF/ErbB Receptors
Burgess, A. W., Cho, H.-S., Eigenbrot, C., Ferguson, K. M., Garrett, T. P. J., Leahy, D. J., Lemmon, M. A., Sliwkowski, M. X., Ward, C. W., & Yokoyama, S. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00350-2 · Cited by 909
EGF Activates Its Receptor by Removing Interactions that Autoinhibit Ectodomain Dimerization
Ferguson, K. M., Berger, M. B., Mendrola, J. M., Cho, H.-S., Leahy, D. J., & Lemmon, M. A. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00047-9 · Cited by 801
Garrett, T. P. J., McKern, N. M., Lou, M., Elleman, T. C., Adams, T. E., Lovrecz, G. O., Zhu, H.-J., Walker, F., Frenkel, M. J., Hoyne, P. A., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00940-6 · Cited by 783
Murine FGFR-1 is required for early postimplantation growth and axial organization.
Deng, C. X., Wynshaw-Boris, A., Shen, M. M., Daugherty, C., Ornitz, D. M., & Leder, P. (1994) · Genes & Development · doi:10.1101/gad.8.24.3045 · Cited by 741
Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas
Cappellen, D., De Oliveira, C., Ricol, D., de Medina, S., Bourdin, J., Sastre-Garau, X., Chopin, D., Thiery, J. P., & Radvanyi, F. (1999) · Nature Genetics · doi:10.1038/12615 · Cited by 713
Cardiac conduction defects associate with mutations in SCN5A
Schott, J.-J., Alshinawi, C., Kyndt, F., Probst, V., Hoorntje, T. M., Hulsbeek, M., Wilde, A. A. M., Escande, D., Mannens, M. M. A. M., & Le Marec, H. (1999) · Nature Genetics · doi:10.1038/12618 · Cited by 640
Chesi, M., Nardini, E., Brents, L. A., Schröck, E., Ried, T., Kuehl, W. M., & Bergsagel, P. L. (1997) · Nature Genetics · doi:10.1038/ng0797-260 · Cited by 637
The ErbB receptors and their role in cancer progression
Holbro, T. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00099-x · Cited by 608
Tavormina, P. L., Shiang, R., Thompson, L. M., Zhu, Y.-Z., Wilkin, D. J., Lachman, R. S., Wilcox, W. R., Rimoin, D. L., Cohn, D. H., & Wasmuth, J. J. (1995) · Nature Genetics · doi:10.1038/ng0395-321 · Cited by 601
Chesi, M., Nardini, E., Lim, R. S. C., Smith, K. D., Kuehl, W. M., & Bergsagel, P. L. (1998) · Blood · doi:10.1182/blood.v92.9.3025 · Cited by 572
FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung
Weinstein, M., Xu, X., Ohyama, K., & Deng, C.-X. (1998) · Development · doi:10.1242/dev.125.18.3615 · Cited by 486
Bellus, G. A., McIntosh, I., Smith, E. A., Aylsworth, A. S., Kaitila, I., Horton, W. A., Greenhaw, G. A., Hecht, J. T., & Francomano, C. A. (1995) · Nature Genetics · doi:10.1038/ng0795-357 · Cited by 473
Glycophorin A dimerization is driven by specific interactions between transmembrane alpha-helices.
Lemmon, M. A., Flanagan, J. M., Hunt, J. F., Adair, B. D., Bormann, B. J., Dempsey, C. E., & Engelman, D. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42569-0 · Cited by 468
Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro
CARPENTER, G., KING, L., & COHEN, S. (1978) · Nature · doi:10.1038/276409a0 · Cited by 454
Structure of the Extracellular Region of HER3 Reveals an Interdomain Tether
Cho, H.-S., & Leahy, D. J. (2002) · Science · doi:10.1126/science.1074611 · Cited by 447
Peters, K., Werner, S., Liao, X., Wert, S., Whitsett, J., & Williams, L. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06631.x · Cited by 427
A point mutation in the neu oncogene mimics ligand induction of receptor aggregation
Weiner, D. B., Liu, J., Cohen, J. A., Williams, W. V., & Greene, M. I. (1989) · Nature · doi:10.1038/339230a0 · Cited by 423
Meyers, G. A., Orlow, S. J., Munro, I. R., Przylepa, K. A., & Jabs, E. W. (1995) · Nature Genetics · doi:10.1038/ng1295-462 · Cited by 390
Model for growth hormone receptor activation based on subunit rotation within a receptor dimer
Brown, R. J., Adams, J. J., Pelekanos, R. A., Wan, Y., McKinstry, W. J., Palethorpe, K., Seeber, R. M., Monks, T. A., Eidne, K. A., Parker, M. W., et al. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb977 · Cited by 368
Two EGF molecules contribute additively to stabilization of the EGFR dimer
Lemmon, M. A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.2.281 · Cited by 367
Vajo, Z., Francomano, C. A., & Wilkin, D. J. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0387 · Cited by 350
Moriki, T., Maruyama, H., & Maruyama, I. N. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4923 · Cited by 337
Mutations that Cause Osteoglophonic Dysplasia Define Novel Roles for FGFR1 in Bone Elongation
White, K. E., Cabral, J. M., Davis, S. I., Fishburn, T., Evans, W. E., Ichikawa, S., Fields, J., Yu, X., Shaw, N. J., McLellan, N. J., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/427956 · Cited by 323
FGFR activation in skeletal disorders: Too much of a good thing
Webster, M. (1997) · Trends in Genetics · doi:10.1016/s0168-9525(97)01131-1 · Cited by 317
Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion.
Bargmann, C. I., & Weinberg, R. A. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03044.x · Cited by 315
A dimerization motif for transmembrane α–helices
Lemmon, M. A., Treutlein, H. R., Adams, P. D., Brünger, A. T., & Engelman, D. M. (1994) · Nature Structural Biology · doi:10.1038/nsb0394-157 · Cited by 314
Webster, M. K., & Donoghue, D. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00384.x · Cited by 307
The Single Transmembrane Domains of ErbB Receptors Self-associate in Cell Membranes
Mendrola, J. M., Berger, M. B., King, M. C., & Lemmon, M. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108681200 · Cited by 303
Clinical spectrum of fibroblast growth factor receptor mutations
Passos-Bueno, M. R., Wilcox, W. R., Jabs, E. W., Serti�, A. L., Alonso, L. G., & Kitoh, H. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(1999)14:2<115::aid-humu3>3.0.co;2-2 · Cited by 293
Chesi, M., Brents, L. A., Ely, S. A., Bais, C., Robbiani, D. F., Mesri, E. A., Kuehl, W. M., & Bergsagel, P. L. (2001) · Blood · doi:10.1182/blood.v97.3.729 · Cited by 289
Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele.
Bange, J., Prechtl, D., Cheburkin, Y. V., Specht, K., Harbeck, N., Schmitt, M., Knyazeva, T., Müller, S., Gärtner, S., Sures, I., et al. (2002) · PubMed · Cited by 275
Jang, J., Shin, K., & Park, J.-G. (2001) · PubMed · Cited by 273
A putative molecular-activation switch in the transmembrane domain of erbB2
Fleishman, S. J., Schlessinger, J., & Ben-Tal, N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252640799 · Cited by 262
Functions of fibroblast growth factors and their receptors
O.M. Wilkie, A., Morriss-Kay, G. M., Yvonne Jones, E., & Heath, J. K. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00102-3 · Cited by 256
EGFR overexpression and radiation response in glioblastoma multiforme
Barker, F. G., Simmons, M. L., Chang, S. M., Prados, M. D., Larson, D. A., Sneed, P. K., Wara, W. M., Berger, M. S., Chen, P., Israel, M. A., et al. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01609-1 · Cited by 243
Yu, X., Sharma, K. D., Takahashi, T., Iwamoto, R., & Mekada, E. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-08-0411 · Cited by 221
Interaction between proteins localized in membranes.
Grasberger, B., Minton, A. P., DeLisi, C., & Metzger, H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.17.6258 · Cited by 215
Iwata, T. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.11.1603 · Cited by 212
Richelda, R., Ronchetti, D., Baldini, L., Cro, L., Viggiano, L., Marzella, R., Rocchi, M., Otsuki, T., Lombardi, L., Maiolo, A. T., et al. (1997) · Blood · doi:10.1182/blood.v90.10.4062 · Cited by 206
Adams, P. D., Arkin, I. T., Engelman, D. M., & Brünger, A. T. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb0295-154 · Cited by 193
The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand
Bouyain, S., Longo, P. A., Li, S., Ferguson, K. M., & Leahy, D. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507591102 · Cited by 192
Olsen, S. K., Ibrahimi, O. A., Raucci, A., Zhang, F., Eliseenkova, A. V., Yayon, A., Basilico, C., Linhardt, R. J., Schlessinger, J., & Mohammadi, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307287101 · Cited by 192
Segatto, O., King, C. R., Pierce, J. H., Di Fiore, P. P., & Aaronson, S. A. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.12.5570 · Cited by 186
Fibroblast growth factor receptor 2 mutations in Beare–Stevenson cutis gyrata syndrome
Przylepa, K. A., Paznekas, W., Zhang, M., Golabi, M., Bias, W., Bamshad, M. J., Carey, J. C., Hall, B. D., Stevenson, R., Orlow, S. J., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-492 · Cited by 185
Beerli, R. R., Graus-Porta, D., Woods-Cook, K., Chen, X., Yarden, Y., & Hynes, N. E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6496 · Cited by 182
Receptor signaling: When dimerization is not enough
Jiang, G., & Hunter, T. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80357-1 · Cited by 181
Structure of the Transmembrane Dimer Interface of Glycophorin A in Membrane Bilayers
Smith, S. O., Song, D., Shekar, S., Groesbeek, M., Ziliox, M., & Aimoto, S. (2001) · Biochemistry · doi:10.1021/bi010357v · Cited by 176
Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1)
Rousseau, F. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.4.509 · Cited by 173
Adams, P. D., Engelman, D. M., & Brünger, A. T. (1996) · Proteins: Structure, Function, and Genetics · doi:10.1002/(sici)1097-0134(199611)26:3<257::aid-prot2>3.0.co;2-b · Cited by 170
RTK mutations and human syndromes: when good receptors turn bad
Robertson, S. C., Tynan, J., & Donoghue, D. J. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(00)02077-1 · Cited by 168
van Rhijn, B. V., van Tilborg, A. V., Lurkin, I., Bonaventure, J., de Vries, A., Thiery, J., van der Kwast, T., Zwarthoff, E., & Radvanyi, F. (2002) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200883 · Cited by 155
Smith, S. O., Smith, C. S., & Bormann, B. J. (1996) · Nature Structural Biology · doi:10.1038/nsb0396-252 · Cited by 147
Mechanism of Transmembrane Signaling: Insulin Binding and the Insulin Receptor
Ottensmeyer, F. P., Beniac, D. R., Luo, R. Z.-T., & Yip, C. C. (2000) · Biochemistry · doi:10.1021/bi0015921 · Cited by 144
Entingh, A. J., & Kahn, C. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313201200 · Cited by 142
Rotational Coupling of the Transmembrane and Kinase Domains of the Neu Receptor Tyrosine Kinase
Bell, C. A., Tynan, J. A., Hart, K. C., Meyer, A. N., Robertson, S. C., & Donoghue, D. J. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.10.3589 · Cited by 141
Ornan, E. M., Adar, R., Feferman, T., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.516-522.2000 · Cited by 140
Schlessinger, J. (2003) · Science · doi:10.1126/science.1082024 · Cited by 121
Kwabi‐Addo, B., Wang, J., Erdem, H., Vaid, A., Castro, P. D., Ayala, G., & Ittmann, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3759 · Cited by 119
Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia
Cho, J. Y., Guo, C., Torello, M., Lunstrum, G. P., Iwata, T., Deng, C., & Horton, W. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2237184100 · Cited by 116
Chimeric NGF-EGF Receptors Define Domains Responsible for Neuronal Differentiation
Yan, H., Schlessinger, J., & Chao, M. V. (1991) · Science · doi:10.1126/science.1850551 · Cited by 115
Signal transduction by epidermal growth factor and heregulin via the kinase-deficient ErbB3 protein
Kim, H., Vijapurkar, U., Hellyer, N. J., Bravo, D., & Koland, J. G. (1998) · Biochemical Journal · doi:10.1042/bj3340189 · Cited by 106
Sulistijo, E. S., Jaszewski, T. M., & MacKenzie, K. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308429200 · Cited by 104
Gerber, D., Sal‐Man, N., & Shai, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400847200 · Cited by 90
Structural analysis of the transmembrane domain of the epidermal growth factor receptor.
Carpenter, C. D., Ingraham, H. A., Cochet, C., Walton, G. M., Lazar, C. S., Sowadski, J. M., Rosenfeld, M. G., & Gill, G. N. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67659-3 · Cited by 82
Tanner, K. G., & Kyte, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35985 · Cited by 80
Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation
Burke, C., Lemmon, M. A., Coren, B. A., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1200873 · Cited by 80
Activation of FGF receptors by mutations in the transmembrane domain
Li, Y., Mangasarian, K., Mansukhani, A., & Basilico, C. (1997) · Oncogene · doi:10.1038/sj.onc.1200983 · Cited by 80
Kashles, O., Szapary, D., Bellot, F., Ullrich, A., Schlessinger, J., & Schmidt, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9567 · Cited by 79
The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk
Frank, B. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh342 · Cited by 78
Li, E., You, M., & Hristova, K. A. (2004) · Biochemistry · doi:10.1021/bi048480k · Cited by 75
Self-citationAdar, R., Ornan, E. M., David, P., & Yayon, A. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.5.860 · Cited by 75
Ikegawa, S., Fukushima, Y., Isomura, M., Takada, F., & Nakamura, Y. (1995) · Human Genetics · doi:10.1007/bf00210413 · Cited by 65
Whitley, P. R., & von HEIJNE, G. (1995) · Advances in cellular and molecular biology of membranes and organelles · doi:10.1016/s1874-5172(06)80004-0 · Cited by 61
The ErbB-4 s80 intracellular domain is a constitutively active tyrosine kinase
Linggi, B. E., Cheng, Q.-C., Rao, A., & Carpenter, G. (2005) · Oncogene · doi:10.1038/sj.onc.1209003 · Cited by 59
Raffioni, S., Zhu, Y., Bradshaw, R. A., & Thompson, L. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.35250 · Cited by 48
Cheatham, B., Shoelson, S. E., Yamada, K. D., Gonçalves, E., & Kahn, C. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7336 · Cited by 44
Yamada, K. D., Carpentier, J., Cheatham, B., Gonçalves, E., Shoelson, S. E., & Kahn, C. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3115 · Cited by 23
Thompson, L. M., Raffioni, S., Wasmuth, J. J., & Bradshaw, R. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.4169 · Cited by 23
Gardin, A., Auzan, C., Clauser, É., Malherbe, T., Aunis, D., Crémel, G., & Hubert, P. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.11.1347 · Cited by 20
Oncogenic activation of the PDGF β receptor by the transmembrane domain of p185neu*
Petti, L. M., Irusta, P. M., & DiMaio, D. (1998) · Oncogene · doi:10.1038/sj.onc.1201590 · Cited by 20
Cited by
Targeting RTK Signaling Pathways in Cancer
Regad, T. (2015) · Cancers · doi:10.3390/cancers7030860 · Cited by 380
Mechanism of FGF receptor dimerization and activation
Sarabipour, S., & Hristova, K. (2016) · Nature Communications · doi:10.1038/ncomms10262 · Cited by 255
Self-citationCalnuc Binds to LRP9 and Affects its Endosomal Sorting
Brodeur, J., Larkin, H., Boucher, R., Thériault, C., St‐Louis, S. C., Gagnon, H., & Lavoie, C. (2009) · Traffic · doi:10.1111/j.1600-0854.2009.00933.x · Cited by 44
AlphaFold2 enables accurate deorphanization of ligands to single-pass receptors
Banhos Danneskiold-Samsøe, N., Kavi, D., Jude, K. M., Nissen, S. B., Wat, L. W., Coassolo, L., Zhao, M., Santana-Oikawa, G. A., Broido, B. B., Garcia, K. C., et al. (2024) · Cell Systems · doi:10.1016/j.cels.2024.10.004 · Cited by 35
Cholesterol promotes the formation of dimers and oligomers of the receptor tyrosine kinase ROR1
Ward, A., Baeza-Ballesteros, L. J., Schuck, R., García-Murria, M. J., Lamichhane, R., Mingarro, I., & Barrera, F. N. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.111000 · Cited by 4
Metadata
- Authors
- Li, E., & Hristova, K.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2006-05-01
- Volume
- 45
- Issue
- 20
- Pages
- 6241-6251
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2082937679
- Cited by
- 258
- References
- 98
- FWCI
- 6.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.